硕肯生物硕肯生物Soken.bio
查看试用产品 →开放浏览 · 登录后申请
人 Gephyrin 抗体对
试剂盒

人 Gephyrin 抗体对

01AB01710

Gephyrin (Gephyrin) is a cytoplasmic, microtubule-associated scaffolding protein essential for organizing the inhibitory postsynaptic density. It functions by anchoring and clustering inhibitory glycine and GABA_A receptors at postsynaptic sites, linking them to the underlying cytoskeleton. Structurally, gephyrin is a modular protein comprising an N-terminal G domain, a C-terminal E domain that binds receptor subunits, and an intrinsically disordered linker that facilitates dynamic oligomerization and synaptic plasticity. Beyond its role in neurotransmission, gephyrin is required for molybdenum cofactor biosynthesis, thereby connecting synaptic function to cellular metabolism. Clinically, pathogenic variants in the GPHN gene are associated with epileptic encephalopathy, hyperekplexia, and intellectual disability due to impaired receptor clustering. Additionally, autoantibodies against gephyrin are identified in stiff-person spectrum disorders, highlighting its involvement in autoimmune neurological conditions.

Human
规格起售价
登录后可查看

技术参数

靶点基因名
GPHN
基因别名
GPH; KIAA1385
蛋白别名
gephyrin; Gephyrin
UniProt
Q9NQX3
物种
Human

产品详情

靶点名称
Gephyrin
蛋白名称
gephyrin
蛋白别名
Gephyrin [Includes: Molybdopterin adenylyltransferase; MPT adenylyltransferase; Domain G); Molybdopterin molybdenumtransferase; MPT Mo-transferase; Domain E]
靶点基因名
GPHN
基因别名
GPH; KIAA1385
UniProt
Q9NQX3
来源物种
Homo sapiens (Human)
物种反应性
Human

背景介绍

Gephyrin (Gephyrin) is a cytoplasmic, microtubule-associated scaffolding protein essential for organizing the inhibitory postsynaptic density. It functions by anchoring and clustering inhibitory glycine and GABA_A receptors at postsynaptic sites, linking them to the underlying cytoskeleton. Structurally, gephyrin is a modular protein comprising an N-terminal G domain, a C-terminal E domain that binds receptor subunits, and an intrinsically disordered linker that facilitates dynamic oligomerization and synaptic plasticity. Beyond its role in neurotransmission, gephyrin is required for molybdenum cofactor biosynthesis, thereby connecting synaptic function to cellular metabolism. Clinically, pathogenic variants in the GPHN gene are associated with epileptic encephalopathy, hyperekplexia, and intellectual disability due to impaired receptor clustering. Additionally, autoantibodies against gephyrin are identified in stiff-person spectrum disorders, highlighting its involvement in autoimmune neurological conditions.